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r:. Mf:I{f'R'is an,,important enzyme in folic acid metabolism and polymorphisnrs C6777
q"d A1298C of the MTHFR gene are being studied for causations of n('n s)'ndromic
,':' clgft lip/palate,,Our aim was to investigate its prevalence and role in Mala'l patients
. as no previous studies are available in this population. Thirty patierrts rvith non
11:,; sindromic cleft liplpalate and their mothers and 30 healthy controls wero inr:luded in
the study. DNA was extracted from blood followed by PCR and RFLP Gr:notyping
,,. :&$ statistical analysis (fisher exact) was done to compare incidenc: of the
po-lymorphisms among cases and the mothers of cleft lip/palate with a control
..,,, 
pd,.pqlaE,.an. The results on genotyping for C677T polymorphism in patients havingI cldft Lrylpalate showed 20o/o heterozygote as compared to I 6.60A among the controls.
Of the mothers 14.4% were heterozygous and 4o/o homozygous for TT variants.
Fisher exact test revealed p value of I and 0.651 respectively on coriparing cases
with controls and mothers with controls for heterozygous genotype. 'fhesc results
being statistically insignificant, indicates possible absence of associati rn ,;f C6777
polymorphism in patients as well as in their mothers with occurr( nc( of cleft
lip/palate. The A1298C polymorphism showed a similar prevalence rate antl possibly
no association with cleft lip/palate. The study indicates the prevalence ol'tht,MTHFR
variants in cleft lip/palate paLients and controls and is similar to the prcvrler 
'lc of thisp,olymorphism quoted fcr other Asian races. Howevcr, the causatior, of non
':'. sy-adromic cleft lip/palate in the Malaysian population clue to either 67-, or 1298
polymorphisms, could not be proved.
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MUTATION ANALYSIS OF THE NON-DELETED SAMPL]IS I-)F
SURVfVAL MOTOR NEURON1 GENE IN SPINAL MUSCULAR AT ]ROPHY
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Spinal Muscular Atrophy (SMA) is the second most frequent atttoso nal recessive
di$ease with a prevalence of 1 out of 6000 newborn and the carner fre<1uetL:y is 1 in
i5r,.,$MA is chaiacterizedby degeneration of the motor neurons in the rtntetior horns
of the spinal cord. Survival Motor Neuron gene (SMN) is a candidate gene for SMA
disease. SMN gene is present in two highly homologous copies SMNI arrd SMN2.
SMN1 and SMN2 genes are composcd of nine exons. Ninety five perce,nt of patients
shgwed a homozygous deletion of exon I and 8. SMNl subtle mutation wair reported
irt,,non-deleted patients and only about 4%o of SMA patients bear one Sll[Nl copy
with an intragenic mutation. DNA was extracted from blood sample; u;ing DNA
extraction kit and subjectcd to SMN I gene deletion analysis according :o t te method
described by van der Steege et al, 1995. Mutation analysis was perforrned in 4 non-
deleted patient and one control using long-range PCR to distinguish be twi,rln SMN1
and 2. Following that, nested PCR fbr exon 3, 4 and 6 were dore. rVe found
substifution G to A in exon 3 in region 273 in one patient and no mutation lu ere found
in the other 3 patients. Quantitative (Real Time) PCR was done to confimt the copy
number of SMNI gene in this patient.
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Computational prediction of eukaryotic promoters is one of the most challenging
problems in sequence analysis . SMN (Survival of Motor Neuron) gene is abt,ut 28 kb
,."' size *iih a total of 9 exons. The two isotypes of Si4/ gene; SMN| and SMNZ
encodes for FL-SMN protein (functional SMN) and ATSMN protein (non functional).
.,..,r tThe lack,,of illdll produces spinal muscular atrophy (SMA) and the increasing gene
f;lir.','dosage oiE'StvnVZ has been shown to decrease the severity of the SMA. 'fhe core
,r,,l'.ri, promoter region of the ,Stl.4ll genes has not been identified but a number of literatures
r,' suggest this gene to be regulated by about 4.6kb region up stream of the transcription
.,, :slaf,t site (TSS). The computational analysis of this region is needed to detect the
..,. 
presence of important features, which can help in developing a strategy for gene
therapy against spinal muscular atrophy (SMA). In this analysis, the open reading
';,, 
,.&ames, Piibnow box sequences, restriction sites and the transcriptional factor binding
. ,..:sites were identified. A total of 6003 restriction sites were determined within l5 open
,.::,,,,:'reading frames. A total of 15 ORFs and 24 nested ORFs wsre determined with 7 and
.,!tl:.:.,t,i;ORFs:l:,r:on the complementary strand. These ORFs contained 15 TA'IA box
',,.::'lrsequences reflecting the diverse function integrity of SMN promoter regiorr. To the
r .' best of our knowledge this is the first reported study in the literature describing the
ORFs, restriction en4rme recognition sites and TATAA box sequences within the
promoter region of SI,O/gene.
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. NORMAL DERMAL FIBROBLASTS AND ITYPERTROPHIC SC-{R
FIBROBLASTS GROWTH CHARACTtrRISTIC IN PRIMARY IIU]IIAN
SKIN CULTURE
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Dermal Jib-rotlasts play a central role in skin tissue regeneration. Fibroltlasts appear
at the injury site at a very early stage and proliferate rapidly as wounrl healing
progresses. Deep dermal injuries will disturb normal healing process lrnd allow an
uncontrolled overproduction of fibroblasts, collagen synthesis and contrectLve tissue
io form hypertrophic scars (hSC). The resulting hSC fibroblasts (hSCF) rran re&ch
qize of more than 4 timcs that of nonnal skin. Thc present study sought tc compare 
.
the growth characteristic of primary human skin fibroblasts derived frorn notmal and
hyper,hophic scar culture. Fibroblasts were maintained in DMEM ruplrlemented
$owh medium in a humidified condition at 370C with 5o/o COz. Cells',vere collected
by,'centrifugation and normal human dermal fibroblasts (nHDF) ancl hliCF were
ieeded at 1x 104 cells/ T-25 flask in 5 ml medium. Flasks were incubat,:d lor 2, 4, 6,
S and'10 days and the growth of nHDF and hSCF were counte<J with 1-131;113c:ytometer
by,using Trypan.Blue Exclusion Test assay. Meaq cell count for nHDF at dzty 2,4,6,
8.,l0was 2x lOaceilslml.5x lOacells/ml.8 >< 10acells/ml, 13x 10acel,s/n, and 30x
101, eells/ml respectively. [T contrast to nHDF,.mean cell count for hSC F at day 2, 4,
6, ''8 and 10'were l7x l}a cells/ml, 36 x 10a cells/ml, 58x 104 cells/ml, 80x 104
ietlslmt and' 100x 10a cellsiml. The calculation of cells growth showed tltere was a
s.iglrificant difference between nHDF and hSCF at each experimentrtl t rne point.
Samples of nHDF and hSCF were used to display a contact inhibiticn ptrttern and
hSCF exhibited linear growth and sustained a higher cellular viabilif' cctnpared to
nHDF.
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GENE EXPRESSION ANALYSIS OF THE EPIDERMAL GROWI'H
FACTOR RACEPTOR AMONG OPERATED ORAL CANCER PA.TI]]:NTS
AT HUSM: A PRELIMINARY REPORT
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Epidermal Growth Factor Receptor (EGFR) gerre, located on chromosom : 7p12,
encodes for a 170 kDa cell surface glycoprotein. EGFR was found to be expr,:ssed in
90Yo of all oral cancer cases. A study was conducted to evaluate the EGFR
expression using Real-Time Polymerase Chain Reaction. The study r,;amples
consisted of five oral cancer patients who underwent surgical treatment at Ilospital
Universiti Sains Malaysia (HUSM). Their medical r"pottr were reviewed :nd the
relevant clinical data werc extracted based on the questionnaire developed by the
Oral Cancer Research and Coordinating Centrc. Total RNA was extracterl from both
tissue samples (normal and tumor) using a commercial RNA extracfion kit. The total
Rb{A was then reverse transcribcd to cDNA. All assays were performed usi tg real-
time RT*PCR, which yields a valuc (Ct) denoting the threshold cycle of PCR
amplification at which product is first detected by fluorescence. The Ct is detendent
on the quantify of the target molecule in the sample. To confrol for variation n RNA
quantity and quality, we used l8S ribosome RNA as an internal control to cal:ulate a
relative Ct for the target moleculc of intcrcst, EGFR. Paired norma'l anc ca^cerous
tissue samples from five oral cancer patients wcre assayed to ascertain he relative
levels of the EGFR EGFR was found to bc increased in tumor tissue as c rmlr rred to
normal tissue inrall samples. Average level of the over expression wa:; 4.1'7 fold.
(Highest: 12^61, Lowest: 0.47). Although with a limited number of sampk:s, orr data
suggested that EGFR may play a role in oral carcinogenesis by pr('rnoting
uncontrolled cell proliferati on.
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The deletion of Survival Motor Neuron | (Slviltil) gene causes the diser,se in about
95o/o of SMA patienls irrespective of clinical severity. Intragenic mutltions were
reported in the remaining 5o/o of the patients. Molecular genetic tesring is now
provided a$'an alternative tool for the muscle biopsy and EMG. Blood samples were
obtained after getting the infonned consent, and DNA was extracted. 
-)eletion
analysis of exons 7 & 8 of the SMN I gene was performed according to van de r Steege
et al (1995). Exons 7 and 8 of the SMNI gene were amplified and diges":d with
restriction enzymes; Dra I and Dde l respectively. One hundred and sixt,:en t;amples
from',government hospitals, medical academic institutions and private hospili,ls from
various parts of Malaysia were received fiorn August 2003 till Novernber 2007. Most
of the samples came from HUSM (27 cases) and HKL (12 cases). Fifty six trrercents
of these cases fulfilled the diagnostic criteria described by the Interna.ionrLl SMA
Consortium.(1998). A total of 31 type I,25 type II and 9 type III SMA prticrLts were
grouped as highly suggestive of clinical SMA. The deletion of at least e;ron 7 of the
SMNI gene was found in 80% of these patients. The dcletion of the ShOrl Ione was
found'to be a major cause for SMA in Malaysian population. The molecular c iagnosis
of SMA has become the preferred diagnostic tool for SMA as the numbe' of r;amples
received increased,by the year.
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